Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LEUPROLIDE vs LEVOCARNITINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LEUPROLIDE vs LEVOCARNITINE: Safety Overview

Metric LEUPROLIDE LEVOCARNITINE
Total FAERS Reports 70,893 392
Deaths Reported 11,858 91
Death Rate 16.7% 23.2%
Hospitalizations 10,499 183
Average Patient Age 67.5 yrs 40.9 yrs
% Female Patients 14.1% 52.6%
FDA Approval Date Apr 14, 2023 Apr 10, 1986
Manufacturer TOLMAR Inc. Saptalis Pharmaceuticals, LLC
Route SUBCUTANEOUS ORAL
Marketing Status Discontinued Prescription